Testosterone Treatment and Fractures in Men with Hypogonadism.

Peter J SnyderDouglas C BauerSusan S EllenbergJane A CauleyKevin A BuhrShalender BhasinMichael G MillerNader S KhanXue LiSteven E Nissen

Published in: The New England journal of medicine (2024)

Among middle-aged and older men with hypogonadism, testosterone treatment did not result in a lower incidence of clinical fracture than placebo. The fracture incidence was numerically higher among men who received testosterone than among those who received placebo. (Funded by AbbVie and others; TRAVERSE ClinicalTrials.gov number, NCT03518034.).

Keyphrases

replacement therapy
middle aged
risk factors
smoking cessation
physical activity
clinical trial
open label
phase iii